51 results

shutterstock_1920759539
COVID-19

Posted on 25.02.2021

The impact of the pandemic on people living with rare diseases

Almost 12 months after the WHO declared a global COVID-19 pandemic, people with rare diseases can reflect on a turbulent year – even if there are some positive lessons to be learned in how services are delivered. While the pandemic continues, most reflections on the crisis come to a common conclusion: everyone suffered, but not […]

By Sandra Courbier Social Research Director - Rare Barometer Programme Lead

shutterstock_430010287
Value

Posted on 02.02.2021

Biobanks and medtech: an underdeveloped partnership

Unlocking academia-industry collaboration on sample collection, storage and sharing  COVID-19 has demonstrated that access to quality samples and clinical data is key to facing any healthcare challenge. Millions of people have been tested around the world, generating an enormous number of samples and patients’ data.  Of course, swabs can have a life after the results […]

By Francesco Florindi Strategy & Partnership Manager, BBMRI-ERIC

shutterstock_1766372960
Digital

Posted on 28.01.2021

Answering the Call of Telehealth

Even before the COVID-19 pandemic, video consultations were on the rise, with many healthcare systems advocating a digital-first approach. In patient care and clinical trials, demand for virtual care has never been higher. The pandemic has accelerated this shift. For me, it has been exciting to collaborate with health systems at a time of urgent […]

By Sorin Stircu Regional MedTech Strategist at E*HealthLine - Europe Global Office

shutterstock_1198926103
COVID-19

Posted on 26.11.2020

In vitro diagnostics at risk: Covid-19 delays progresses towards the new European regulations

In order to keep them available to the health care system and to patients, more than 85% of IVDs will need to be updated in view of the new in vitro Diagnostic Regulation (IVDR) which is at risk due to the ongoing COVID-19 pandemic. The remaining IVDR transition time is not sustainable and requires attention […]

By Natale Bova Chair of the Regulatory IVD Forum of Confindustria Dispositivi Medici

shutterstock_786971899
COVID-19

Posted on 30.10.2020

Planning ahead – with clear data

With more than 45 million confirmed cases and more than 1 million deaths at the time of writing, the coronavirus pandemic has wreaked havoc in virtually all countries around the world. Beyond grinding day-to-day life to a halt, the ongoing situation has prompted a reckoning throughout the health care industry, which is facing unprecedented challenges […]

By Kathleen Van Vlierberghe Senior Director, Healthcare Solutions and Partnerships, EMEA at Boston Scientific

shutterstock_1357664711
COVID-19

Posted on 26.10.2020

COPD & COVID-19: Pandemic must prompt shift to connected care

For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact. The pandemic has disrupted traditional models of care and put vulnerable patients at risk. Keeping patients out of hospital – by reducing scheduled visits and avoiding emergency admissions – has become the top priority.  A silver […]

By Odile Bigaignon Vice President, EMEA Marketing at ResMed

shutterstock_1686020212
COVID-19

Posted on 20.10.2020

In crisis, medtech found the path to realise its full potential

I have been truly humbled by the collective response of the medical technology industry through this pandemic. As we approach MedTech Week 2020, our industry can be proud of the contribution we have made. But as we reflect on the impact of this unprecedented year, perhaps the true legacy has yet to reveal itself: how […]

By Eric Thépaut Senior Vice President and President, EMEA - Boston Scientific

shutterstock_1323264992
COVID-19

Posted on 29.09.2020

Your heart has never been more important

The unprecedented COVID-19 has fundamentally shifted society’s and government’s attention and prioritisation of healthcare. Never has health topped our agenda as much as today – as an individual trying to stay healthy, as healthcare professional and facility trying to deliver a high quality of care, as industry trying to deliver the best innovations to improve […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada, Latin America and JAPAC & Chair of the Cardiovascular Sector Group of MedTech Europe

shutterstock_1498583432
Research & Innovation

Posted on 21.09.2020

EU Health PPP: a new era for medtech companies

For decades, companies in the medtech and pharma sectors have delivered healthcare innovations separately – collaboration has been limited. However, we know that this is not how patients experience healthcare. In the real world, diagnostics, devices, medicines, vaccines and digital tools combine to keep people healthy and to treat those who are unwell.  This reality […]

By Philippe Cleuziat Senior Director, R&D Department Open Innovation & Partnerships at bioMerieux